AddedRisk Factors
business. Even if we are successful in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedRisk Factors
We are a “covered entity” as defined under HIPAA when we provide our clearinghouse services, and we also are a “business associate” as defined under HIPAA for other covered entities when we provide revenue cycle management and other solutions. HHS OCR may impose civil penalties on both covered entities and business associates for their failure to
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedRisk Factors
expect even greater scrutiny by federal and state regulators, partners, and consumers of our Processing of health information, particularly with our AI-enabled solutions. Additionally, federal and state consumer protection laws are increasingly being applied by the FTC and states’ attorneys general to regulate the Processing of personal information, through websites or otherwise, and to regulate the presentation of website content.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedRisk Factors
As a public company, we are subject to significant requirements for enhanced financial reporting and internal controls. The process of designing and maintaining effective internal controls is a time consuming, costly, and continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments. If
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RemovedRisk Factors
sale of these technologies, or their use by us or by our clients or partners, may also subject us to additional risks, including reputational harm, competitive harm, or legal liabilities.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to “emerging growth companies” will make our common stock less attractive to investors.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, and we may take advantage of certain exemptions and relief from various reporting requirements that are applicable to other public companies that are not “emerging growth companies.” In particular, while we are an “emerging growth company,” among other exemptions:
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will not be required to engage an independent registered public accounting firm to report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act,
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will be subject to reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will not be required to comply with the requirement in Public Company Accounting Oversight Board Auditing Standard 3101, The Auditor’s Report on an Audit of Financial Statements When the Auditor Expresses an Unqualified Opinion, to communicate critical audit matters in the auditor’s report;
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will be permitted to present only two years of audited financial statements and only two years of related “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our periodic reports and registration statements;
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will not be required to disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation; or
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
we will not be required submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency,” and “say-on-golden parachutes.”
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards, meaning that we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of this extended transition period, and as a result, our financial statements may not be comparable with similarly situated public companies.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We will remain an “emerging growth company” until the earliest to occur of (1) our reporting of $1.24 billion or more in annual gross revenue; (2) our becoming a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates; (3) our issuance, in any three year period, of more than $1.0 billion in non-convertible debt; and (4) the fiscal year end following the fifth anniversary of the completion of our initial public offering.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
We cannot predict whether investors will find our common stock less attractive if we rely on the exemptions and relief granted by the JOBS Act. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be as comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may decline and/or become more volatile.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedRisk Factors
See Part I, Item 1A, “Risk Factors—Risks Related to Information Technology Systems, Cybersecurity, Data Privacy, and Intellectual Property—Privacy concerns or security breaches or incidents relating Property—Our business is subject to our platform could result in economic loss, damage to our reputation, deter users from using our products, expose us to legal penalties complex and liability, evolving laws and otherwise adversely affect our business” regulations regarding privacy, data protection, and cybersecurity and Part I, Item 1A, “Risk Factors—Risks Related to Legal and Governmental Regulation—We are subject to health care laws and data privacy and security laws and regulations governing our Processing of personal information, including PHI, personal health records, and payment card data.”
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we are determined to have violated any of these laws, we may be required to give our clients the right to terminate our services agreements with them and/or required to refund portions of our base fee revenues and incentive payment revenues, any of which could have a material adverse effect on our business and results of operations.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any theft, loss, or misappropriation of, or access to, clients’, or other proprietary data, or other breach of our third-party service providers’ or vendors’ information technology systems Additionally, any such event could result in fines, legal claims, or proceedings, including regulatory investigations and class actions, or liability for failure to comply with privacy and information security laws, which could disrupt our operations, damage our reputation, and expose us to claims from clients, individuals, and others, any of which could have a material adverse effect on our business, financial condition, and results of operations.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Many other states, such as Colorado, Connecticut, Delaware, Indiana, Iowa, Kentucky, Maryland, Minnesota, Montana, Nebraska, New Hampshire, New Jersey, Oregon, Rhode Island, Tennessee, Texas, Utah, and Virginia states have since also passed enacted comprehensive state privacy laws that may impose additional obligations and requirements on our business.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, the Revolving Credit Facility requires us to maintain a first lien leverage ratio, to be tested on the last day of each fiscal quarter for which financial statements have been delivered, but only if, on the last day of such fiscal quarter, the aggregate amount of loans under the Revolving Credit Facility and certain letters of credit (in each case subject to certain exceptions specified therein) which are outstanding and/or issued, as applicable, exceeds 35% of the total amount of the commitments in respect of the Revolving Credit Facility.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Bain has the right to nominate to our board of directors one nominee for so long as Bain beneficially owns 5% or greater of our then-outstanding common stock.Advent has the right to nominate to our board of directors one nominee for so long as Advent beneficially owns 5% or greater of our then-outstanding common stock.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Recent and future government actions, including federal government cost-cutting, efficiency, and fraud and abuse initiatives may also result have a significant adverse impact on our business, and legislation or executive actions could limit or attempt to limit government spending for Medicare and Medicaid programs, limit payments to healthcare providers, initiate new and expanded value-based care reimbursement programs, impose price controls, and create other programs that potentially could have an adverse effect on our clients and the other entities with which we have a business relationship.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
While certain of these rules benefit us in that certain EHR vendors will no longer be permitted to interfere with our attempts at integration, they may also make it easier for other similar companies to enter the market, creating increased competition and reducing our market share. share.Changes to the legal, regulatory or political environment may require management’s attention, divert resources from other areas, and expose us to potential liability.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
If providers of EHR or PM solutions amend, terminate, or fail to perform their obligations under their agreements with us, we may need to seek other ways of integrating our platform with the EHR and PM systems of our clients, which could be costly and time consuming, and could adversely affect our business results.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we believe we have taken reasonable steps to protect such data, techniques Techniques used to gain unauthorized access to or acquisitions of data and systems, disable or degrade service, or sabotage systems, are constantly evolving, evolving (including through the use of AI), and we may be unable to anticipate such techniques or implement adequate preventative measures to avoid unauthorized access, acquisitions of, or other adverse impacts to such data or our systems.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Although we carry cybersecurity insurance, we cannot ensure our limits are sufficient to cover us against all potential losses for damages or fines in an amount exceeding our policy. policy, or that applicable insurance will be available to us in the future on economically reasonable terms or at all.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Healthcare laws and regulations are rapidly evolving evolving, including as a result of changes in the U.S. administration resulting in changes in federal law and enforcement, and may change significantly in the future, which could adversely affect our financial condition and results of operations.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Even though we provide for appropriate certain protections through our agreements with our subcontractors, we still have limited control over their actions and practices.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
On February 24, 2025, the Institutional Investors closed an underwritten public offering of 23,000,000 shares of our common stock (inclusive of the underwriters’ option to purchase additional shares) (the “First Secondary Offering”). On May 15, 2025, the Institutional Investors closed another underwritten public offering of 14,375,000 shares of our common stock (inclusive of the underwriters' option to purchase additional shares) (the "Second Secondary Offering"). Additionally, on September 10, 2025, the Institutional Investors closed another underwritten public offering of 18,000,000 shares of our common stock (the "Third Secondary Offering"). We did not sell any shares in these offerings or receive any proceeds from these offerings. Pursuant to the terms of the Amended and Restated Registration Rights Agreement, dated as of June 10, 2024, by and among Waystar, the Institutional Investors, and certain other parties thereto, we paid $4.6 million in certain expenses on behalf of the selling stockholders related to these offerings for the year ended December 31, 2025, while the selling stockholders paid all applicable underwriting discounts and commissions.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
On July 23, 2025, we entered into an Agreement and Plan of Merger (the "Merger Agreement") to acquire Iodine through a series of mergers. Iodine is a trusted leader in AI-powered clinical intelligence, enhancing clinical documentation and accuracy, streamlining utilization management, and preventing revenue leakage before billing. This strategic move is expected to bolster our AI leadership, automate manual work, and improve financial performance for providers. The acquisition was completed on October 1, 2025 for a total purchase price of $1.26 billion. The consideration paid was approximately $638.9 million in cash consideration and 16,639,920 shares of common stock having a value of $37.31 per share, and certain adjustments as outlined in the Merger Agreement.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
The following discussion and analysis is for the year ended December 31, 2025, compared to the same period in 2024, unless otherwise stated. For a discussion and analysis of the year ended December 31, 2024, compared to the same period in 2023, please refer to the Management's Discussion and Analysis of Financial Condition and Results of Operations
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 18, 2025.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, and non-GAAP net income per share are not recognized terms under GAAP and should not be considered as an alternative to net income/(loss), net income/(loss) per share or net income/(loss) margin as measures of financial performance or cash provided by operating activities as a
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Years ended December 31, ($in thousands) 2025 2024 Net income/(loss) $ 112,089 $ (19,125) Interest expense 77,542 146,270 Income tax expense/(benefit) 59,674 (3,420) Depreciation and amortization 140,548 186,631 Stock-based compensation expense 42,069 54,437 Acquisition and integration costs 21,074 859 Costs related to amended debt agreements 2,580 14,138 IPO and Secondary Offering related expenses 4,657 2,140 Other (a) 1,913 1,566 Adjusted EBITDA $ 462,146 $ 383,496 Revenue $ 1,099,278 $ 943,549 Net income/(loss) margin 10.2 % (2.0) % Adjusted EBITDA margin 42.0 % 40.6 %
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Years ended December 31, ($in thousands) 2025 2024 Net income/(loss) $ 112,089 $ (19,125) Stock-based compensation expense 42,069 54,437 Acquisition and integration costs 21,074 859 Costs related to amended debt agreements 2,580 14,138 IPO and Secondary Offering related expenses 4,657 2,140 Other (a) 1,913 19,445 Intangible amortization 118,609 147,887 Tax effect of adjustments (40,089) (50,170) Non-GAAP net income/(loss) $ 262,902 $ 169,611 Non-GAAP net income/(loss) per share: Basic $ 1.48 $ 1.13 Diluted $ 1.42 $ 1.09 Weighted-average shares outstanding: Basic 177,926,745 149,915,839 Diluted 184,783,285 155,677,094
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year ended December 31, (For the 12 month period ended) 2025 2024 Customer Count with > $100,000 Revenue 1,391 1,203
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
On October 1, 2025, we entered into the Twelfth Amendment to the First Lien Credit Agreement to increase our First Lien Credit Facility by $250.0 million. Additionally, the amendment increased the maximum borrowing capacity under the revolving credit facility from $400.0 million to $500.0 million and decreased the interest rate under the Revolving Credit Facility from 1.75% per annum above SOFR to 1.50% per annum above SOFR.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
The results of businesses acquired in business combinations are included in our consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business being recorded at their estimated fair values on the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. The purchase price allocation process requires management to make significant judgment and estimates, including the selection of valuation methodologies, estimates of future expected cash flows, future revenue growth, margins, customer attrition rates, technology life, royalty rates, expected use of acquired assets, and discount rates. These factors are also considered in determining the useful life of the acquired intangible assets. These estimates are based in part on historical experience, market conditions and information obtained from management of the acquired companies and are inherently uncertain. We engage the assistance of valuation specialists in concluding on fair value measurements in connection with determining fair values of assets acquired and liabilities assumed in business combinations.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RemovedMD&A
Included within the revenue increases over the period is an estimated $34 million increase due to our heightened win rates above our historically high rates and accelerated implementation timelines as well as increased volume-based revenue from existing clients related to the cybersecurity incident involving one of our competitors in February 2024.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
(b) Reflects the impact of the impairment expense recognized related to leasehold improvements and right-of-use assets at closed office locations.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
(b) Reflects the impact of the impairment expense recognized related to leasehold improvements and right-of-use assets at closed office locations.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
On December 1, 2019, the Borrower and certain lenders amended the First Lien Credit Agreement to add 2019 first lien incremental term loans in the amount of $100.0 million to be used for certain acquisitions consummated substantially simultaneously with the closing of such amendment. The terms of such 2019 first lien incremental term loans were the same as the terms of the initial first lien term loans, including in respect of maturity, and were considered an increase in the aggregate principal amount of the initial first lien term loans outstanding under the First Lien Credit Agreement and were part of the initial first lien term loans.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
On September 23, 2020, the Borrower and certain lenders amended the First Lien Credit Agreement to (i) add 2020 first lien incremental term loans in the amount of $620.0 million to be used for certain acquisitions consummated substantially simultaneously with the closing of such amendment and (ii) add revolving credit commitments in the amount of $75.0 million to increase the revolving credit commitments available under the First Lien Credit Agreement to $200.0 million. Such 2020 first lien incremental term loans constituted a separate class of first lien term loans from the initial first lien term loans but were otherwise on the same as the terms of the initial first lien term loans (other than with respect to the “LIBOR-floor” applicable thereto).
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
On March 24, 2021, the Borrower and certain lenders amended the First Lien Credit Agreement to (i) reduce the “LIBOR-floor” applicable to the 2020 first lien incremental term loans and (ii) in connection therewith, combine the initial first lien term loans with the 2020 first lien incremental term loans which thereafter then constituted one class of first lien term loans.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
On August 24, 2021, the Borrower and certain lenders amended the First Lien Credit Agreement to add 2021 first lien incremental term loans in the amount of $247.0 million to be used for certain acquisitions consummated substantially simultaneously with the closing of such amendment. The terms of such 2021 first lien incremental term loans were the same as the terms of the initial first lien term loans outstanding at such time, including in respect of maturity, and were considered an increase in the aggregate principal amount of the initial first lien term loans outstanding under the First Lien Credit Agreement at such time and were part of the initial first lien term loans.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
On October 6, 2023, the Borrower and certain lenders amended the First Lien Credit Agreement to, among others, (i) increase the revolving credit commitments under the First Lien Credit Agreement by $142.5 million to a total of $342.5 million, with a sub-commitment for issuance of letters of credit of $50.0 million, (ii) amend the applicable margin with respect thereto upon the consummation of a qualifying initial public offering, and (iii) extend the availability period of such revolving credit commitments and the maturity date of loans thereunder from October 22, 2024 to October 6, 2028; provided that if, prior to October 6, 2028, either (i) on the date that is 91 days prior to the maturity date of the first lien term loans (or any loans refinancing such first lien term loans), more than $150.0 million of such first lien term loans (or any such loans refinancing such first lien term loans) are outstanding or (ii) on the date that is 91 days prior to the maturity date of the second lien term loans under the Second Lien Credit Facility (or any loans refinancing such second lien term loans), any such second lien term loans (or any such loans refinancing such second lien term loans) are outstanding, the commitments under the revolving credit facility and the loans thereunder will terminate and mature on such date (the “Springing Maturity Condition”). The revolving credit commitments as increased by the amendment replaced the existing revolving credit commitments under the First Lien Credit Agreement.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
We are currently an “emerging growth company,” as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedMD&A
Revenue was $1,099.3 million for the year ended December 31, 2025 as compared to $943.5 million for the year ended December 31, 2024 as compared to $791.0 million for the year ended December 31, 2023, 2024, an increase of $152.5 $155.7 million, or 19.3%, 16.5%, of which $57.0 $100.4 million was attributed to subscription revenue from new and existing clients, with $54.8 million almost all of which is generated by provider solutions, and $2.2 million generated from patient payments solutions.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Our indirect wholly-owned subsidiary, Waystar Technologies, Inc., a Delaware corporation (the “Borrower”), is the Borrower under a first lien credit agreement, originally dated as of October 22, 2019 (as amended from time to time, the “First Lien Credit Agreement”), that initially provided for an $825.0 million senior secured first lien term loans and commitments under a revolving credit facility in an aggregate principal amount of $125.0 million, with a sub-commitment for issuance of letters of credit of $25.0 million. Agreement”).
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
For the year ended December 31, 2024, 2025, we generated revenue of $943.5 $1,099.3 million (reflecting a 19.3% 16.5% increase compared to revenue of $791.0 $943.5 million for the same period in the prior year), net loss income of $19.1 $$112.1 million (compared to net loss of $51.3 $19.1 million for the same period in the prior year), and Adjusted EBITDA of $383.5 $462.1 million (reflecting a 14.9% 20.5% increase compared to Adjusted EBITDA of $333.7 $383.5 million for the same period in the prior year).
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Depreciation and amortization expense was $140.5 million for the year ended December 31, 2025, as compared to $186.6 million for the year ended December 31, 2024, as compared to $176.5 million for the year ended December 31, 2023, an increase a decrease of $10.2 $46.1 million, or 5.8%. 24.7%.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Sales and marketing expense was $178.0 million for the year ended December 31, 2025 as compared to $156.9 million for the year ended December 31, 2024 as compared to $124.4 million for the year ended December 31, 2023, 2024, an increase of $32.5 $21.1 million, or 26.1%. 13.4%.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
(a) Adjustments (a)For the year ended December 31, 2025, adjustments relate to additional lease costs of $1.6 million and accelerated depreciation of $17.9 million due to the relocation of our Louisville office. office totaling $1.3 million and executive severance totaling $0.6 million.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
(a) Adjustments (a)For the year ended December 31, 2025, adjustments relate to additional lease costs of $1.6 million and accelerated depreciation of $17.9 million due to the relocation of our Louisville office. office totaling $1.3 million and executive severance totaling $0.6 million.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Cash flows provided by financing activities were $243.5 million for the year ended December 31, 2025 as compared to $16.7 million for the year ended December 31, 2024 as compared to cash flows used of $17.2 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
The tax effects of the adjustments are calculated using a management estimated annual effective non-GAAP tax rate of 21%. 21%, which is based on our statutory federal tax rate and provides consistency across reporting periods by eliminating the effects of non-recurring and period specific items.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Cash flows provided by operating activities were $309.7 million for the year ended December 31, 2025 as compared to $169.8 million for the year ended December 31, 2024 as compared to $51.5 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Cash flows used in investing activities were $680.9 million for the year ended December 31, 2025 as compared to $27.3 million for the year ended December 31, 2024 as compared to $61.5 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
The increase was These increases were partially offset by a decrease due to the proceeds from our IPO net of third-party IPO issuance costs (see Part II, Item 8, “Financial Statements—Note 1”), 1”) during the year ended December 31, 2024, as well as the issuance of debt, net of creditor fees (see Part II, Item 8, “Financial Statements—Note 11). 13) in the prior period.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new